MIRA INFORM REPORT

 

 

 

 

Report Date :

10.04.2012

 

IDENTIFICATION DETAILS

 

Name :

EMS S/A

 

 

Formerly Known As :

EMS INDÚSTRIA FARMACÊUTICA LTDA

 

 

Registered Office :

Rod Jornalista Francisco Aguirre Proenca, S/Nº Km 08 Bloco I, Ii E V - Chacara Assay

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

09.01.1964

 

 

Legal Form :

Privately Held Corporation

 

 

Line of Business :

Manufacturer Of Pharmaceuticals

 

 

No. of Employees :

4600

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 5.000.000,00

 

 

Status :

Good

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

                   (31.12.2011)                  

Current Rating

(31.03.2012)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name

 

EMS S/A

 

 

company ADDRESSES

 

MAIN ADDRESS:

ROD JORNALISTA FRANCISCO AGUIRRE PROENCA, S/Nº KM 08 BLOCO I, II E V - CHACARA ASSAY

ZIP CODE/CITY:

13.186-901 - HORTOLANDIA/SP

 

 

PHONE:

19 3887-9800

FAX:

19 3887-9504

E-MAIL:

wagner@ems.com.br

WEB SITE:

www.ems.com.br

 

BRANCHES:

 

 

 

ADDRESS:

AVENIDA A,27 A, CJ MARCOS FREIRE II - TAICOCA

ZIP CODE/CITY:

49160-000 NOSSA SENHORA DO SOCORRO/SE

CNPJ:

57.507.378/0005-27

 

 

ADDRESS:

SAA NORTE, QUADRA 02,960

ZIP CODE/CITY:

70632-200 BRASÍLIA/DF

PHONE:

61 3363-4309

CNPJ:

57.507.378/0006-08

 

 

ADDRESS:

RUA MONSENHOR OTÁVIO DE CASTRO,167 - VILA UNIÃO

ZIP CODE/CITY:

60410-691 FORTALEZA/CE

CNPJ:

57.507.378/0007-99

 

 

ADDRESS:

RUA 1.126, QUADRA 230, LOTE 2, CASAS 1 E 2,0 - SETOR MARISTA

ZIP CODE/CITY:

74175-050 GOIÂNIA/GO

CNPJ:

57.507.378/0008-70

 

 

ADDRESS:

RUA COM CARLO MARIO GARDANO,450 - CENTRO

ZIP CODE/CITY:

09.720-47 SAO BERNARDO DO CAMPO/SP

PHONE:

11 2104-1677

CNPJ:

57.507.378/0001-01

STATE REGISTER:

635.038.454.114

 

 

ADDRESS:

268 MUNOZ RIVERA AVE, WESTERNBANK WORLD PLAZA, SUÍTE,808 - SAN JUAN

ZIP CODE/CITY:

PORTO RICO, PR 00918

 

 

ADDRESS:

RUA COMENDADOR CARLO MARIO GARDANO,450 - VILA SANTA RITA DE CÁSSIA

ZIP CODE/CITY:

09720-470 SÃO BERNARDO DO CAMPO/SP

CNPJ:

57.507.378/0001-01

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICALS.

 

LEGAL FORM:

PRIVATELY HELD CORPORATION

 

 

INCORPORATION DATE:

09/01/1964

REGISTER DATE:

09/01/1964

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

57.507.378/0003-65

STATE REGISTER:

748.002.161.113

 

 

SHARE CAPITAL:

R$ 221.716.503,42

LAST REGISTER OF CAPITAL:

12/08/2010

 

BOARD OF DIRECTORS:

 

 

 

LUIZ CARLOS BORGONOVI

PRESIDENT DIRECTOR

WALDIR ESCHBERGER JUNIOR

VICE-PRESIDENT DIRECTOR

CLARICE MITIE SANO YUI

VICE-PRESIDENT DIRECTOR

ISRAEL DOMINGUES BACCA

VICE-PRESIDENT DIRECTOR

JOSE CARLOS JORGE LIMA BUECHEM

VICE-PRESIDENT DIRECTOR

VINZENZ PLORER

VICE-PRESIDENT DIRECTOR

 

 

AUTHORIZED USE OF SIGNATURE

 

THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

EMS PARTICIPAÇÕES S/A

99,99%

GERMED FARMACEUTICA LTDA

0,01%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

LEGRAND PHARMA INDUSTRIA FARMACÊUTICA LTDA

99,00%

TOPZ INDUSTRIA E COMERCIO DE COSMÉTICOS LTDA

99,00%

GERMED FARMACÊUTICA LTDA

99,00%

EMS SIGMA FARMA LTDA

99,00%

SIGMA FARMA EMS, LLC

100,00%

 


COMPANY'S BACKGROUND

 

THE HISTORY OF EMS SIGMA PHARMA GROUP STARTS IN 1964, IN THE CITY OF SANTO ANDRÉ, WHEN THE PHARMACY CALLED SANTA CATARINA WAS ESTABLISHED BY EMILIANO SANCHEZ. AFTER 13 YEARS OF HARD WORK, DEDICATION AND GROWING, THE SMALL PHARMACY WAS TRANSFORMED INTO THE LABORATORY CALLED EMS.

 

DURING THE FOLLOWING YEARS, AS PART OF THEIR EXPANSION STRATEGY, THE LABORATORIES LEGRAND AND NOVAQUÍMICA WERE PURCHASED, FURTHER TO THE EXPANSION OF THE PRODUCTS LINE AND THE SEGMENT OF ACTIVITY, COMPLETING THE COMPANY'S PORTFOLIO.

 

CURRENTLY, THE GROUP IS COMPOSED BY THE COMPANIES EMS, LEGRAND, SIGMA PHARMA AND NATURE'S, ACTING IN THE PHARMACEUTICAL, GENERIC, CONSUME, HOSPITAL AND PERSONAL HYGIENE SEGMENTS. THE GROUP HAS AS HIGHLIGHT IT PIONEER CONDITION WITH GENERIC MEDICATIONS, BEING THE FIRST COMPANY TO RECEIVE THE APPROVAL OF ANVISA TO MANUFACTURE AND MERCHANDISE THE MEDICATION CALLED CYCLOSPORINE, WHICH IS DESTINED TO AVOID THE REJECTION OF TRANSPLANT ORGANS.

 

ONE OF THE LARGEST COMPANIES WITH ASSETS CAPITAL BEING 100% NATIONAL, IN 39 YEARS OF ACTIVITY IN THE BRAZILIAN MARKET, REACHED THE 11TH PLACE IN THE PHARMACEUTICAL INDUSTRIES RANKING (SOURCE: IMS HEALTH, 2002).

 

THE GROUP HAS TWO PRODUCTION UNITS LOCATED IN SÃO BERNARDO DO CAMPO AND HORTOLÂNDIA, SP, BEING THE LAST ONE THE MOST UPDATED COMPANY OF LATIN AMERICA, STRUCTURED ACCORDING TO THE STANDARDS ESTABLISHED BY THE FDA (FOOD AND DRUG ADMINISTRATION).

 

WITH 2,800 EMPLOYEES DISTRIBUTED IN THE ADMINISTRATION, COMMERCIAL AND INDUSTRIAL AREAS, THE EMS SIGMA PHARMA GROUP MANUFACTURES AND MERCHANDISE FOR ALL THE COUNTRY MORE THAN 350 PRODUCTS, ALL OF THEM MANUFACTURED UNDER THE MOST STRICT QUALITY STANDARDS, CONTRIBUTING IN THIS WAY TO IMPROVE THE HEALTH AND QUALITY OF LIFE OF ALL BRAZILIANS

 

ON DECEMBER 17, 2002 THE SUBJECT COMPANY CHANGED ITS CORPORATE NAME FROM EMS INDÚSTRIA FARMACÊUTICA LTDA TO THE CURRENT ONE.

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

PUBLIC RECORDS INFORMATION:

 

PROTESTS:

 

1  PROTEST,TOTAL AMOUNT R$ 3.630,00

 

DETAILS OF LATEST PROTESTS:

 

NOTARY OFFICE:

DATE:

VALUE:

1º CARTORIO DE SUMARE/SP

18/10/2011

R$ 3.630,00

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

6

STATE LAWSUITS

25/10/11

1ª VARA DE SP-HORTOLÂNDIA

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2010, 31/12/2009 AND 31/12/2008.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2010

31/12/2009

31/12/2008

 

 

 

 

CASH AND BANKS

10.338

25.783

22.070

CLIENTS

309.885

240.525

196.032

INVENTORY

147.183

139.565

144.952

OTHER CREDITS

2.711

3.919

5.039

INTERCOMPANY CREDITS

109.063

9.187

31.745

RECOVERABLE TAXES

11.778

21.004

31.553

DEFERRED TAXES

 

54.495

83.891

INVESTMENTS

 

6.848

4.086

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

590.958

501.326

519.368

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

JUDICIAL DEPOSITS

8.241

6.331

 

DEFERRED TAXES

35.208

18.472

43.212

INTERCOMPANY CREDITS

79.464

233.231

171.518

RECOVERABLE TAXES

3.058

3.058

4.729

INVESTMENTS

14.846

12.754

 

OTHER CREDITS

2.640

2.900

1.702

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

143.457

276.746

221.161

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

39.744

24.947

38.768

FIXED ASSETS

132.263

133.498

138.261

INTANGIBLE

3.038

5.869

7.787

DEFERRED

 

 

26.103

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

175.045

164.314

210.919

 

================

================

================

TOTAL ASSETS

909.460

942.386

951.448

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2010

31/12/2009

31/12/2008

 

 

 

 

LOANS AND FINANCING

32.365

16.821

15.821

SUPPLIERS

64.529

43.540

93.967

INTERCOMPANY DEBTS

4.731

1.648

1.086

ACCOUNTS PAYABLE

8.549

7.625

6.886

PROVISIONS

 

3.086

1.827

INSTALLMENTS TAXES PAYABLE

12.469

12.197

7.885

INCOME TAX/SOCIAL CONTRIBUTION

24.970

 

 

TAX LIABILITIES

10.822

11.659

12.317

SOCIAL / LABOR OBLIGATIONS

23.015

15.576

11.282

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

181.450

112.152

151.071

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

123.961

126.120

133.098

INSTALLMENTS TAXES PAYABLE

21.398

28.005

30.838

PROVISION FOR CONTINGENCIES

58.313

54.328

47.833

DEFERRED TAXES

429

 

18.690

OTHER

2.561

5.408

6.831

DEFERRED REVENUE

79.691

72.996

 

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

286.353

286.857

237.290

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

221.708

221.717

120.073

CAPITAL RESERVES

164.019

164.019

265.663

PROFIT RESERVES

55.930

157.641

177.352

 

----------------

----------------

----------------

TOTAL NET EQUITY

441.657

543.377

563.088

 

================

================

================

TOTAL LIABILITIES

909.460

942.386

951.449

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2010, 31/12/2009 AND 31/12/2008.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

 

31/12/2010

31/12/2009

31/12/2008

 

 

 

 

GROSS SALES

 

 

1.002.017

(-) TAXES ON SALES

 

 

172.235

 

----------------

----------------

----------------

NET SALES

1.213.283

1.036.807

829.782

(-) COST OF SOLD GOODS

444.871

440.225

394.200

 

----------------

----------------

----------------

GROSS PROFIT

768.412

596.582

435.582

OPERATING REVENUE (EXPENSE)

-433.523

-368.082

-241.141

FINANCIAL REVENUE(EXPENSE)

-8.271

3.584

-25.175

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

326.618

232.084

169.266

CONTRIBUTION/INCOME TAX

-91.937

-67.038

-96.384

 

----------------

----------------

----------------

NET PROFIT (LOSS)

234.681

165.046

72.882

 

RATIOS:

31/12/2010

31/12/2009

31/12/2008

 

QUICK RATIO

2,45

 

3,23

 

2,48

 

CURRENT RATIO

3,26

 

4,47

 

3,44

 

ACCOUNTS RECEIVABLE TURNOVER

3,92

TIMES

4,31

TIMES

4,23

TIMES

DAYS' SALES IN RECEIVABLES

91,95

DAYS

83,52

DAYS

85,05

DAYS

INVENTORY TURNOVER

3,02

TIMES

3,15

TIMES

2,72

TIMES

ACCOUNTS PAYABLE PERIOD

52,22

DAYS

35,61

DAYS

85,81

DAYS

RETURN ON ASSETS

1,33

TIMES

1,10

TIMES

,87

TIMES

SALES TURNOVER ON NET EQUITY

2,75

TIMES

1,91

TIMES

1,47

TIMES

NET WORTH TIE-UP

,30

 

,25

 

,25

 

INDEBTEDNESS

1,06

 

,73

 

,69

 

EQUITY RATIO

48,56

%

57,66

%

59,18

%

WORKING CAPITAL RATIO

225,69

%

347,01

%

243,79

%

GENERAL SOLVENCY

1,94

 

2,36

 

2,45

 

RETURN ON NET EQUITY

53,14

%

30,37

%

12,94

%

RETURN ON SALES (PROFIT MARGIN)

19,34

%

15,92

%

8,78

%

GROSS PROFIT MARGIN

63,33

%

57,54

%

52,49

%

OPERATIONAL RESULT

26,92

%

22,38

%

20,40

%

SALES TURNOVER ON LIABILITIES

6,69

TIMES

9,24

TIMES

5,49

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 1,83

 - OFFICIAL RATE ON 04/04/2012

US$ 1,00 = R$ 1,66

 - OFFICIAL RATE ON 31/12/2010

US$ 1,00 = R$ 1,74

 - OFFICIAL RATE ON 31/12/2009

US$ 1,00 = R$ 2,33

 - OFFICIAL RATE ON 31/12/2008

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A GOOD FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS HIGH BUT IT HAS HIGH LIQUIDITY RATIOS AND IMPORTANT WORKING CAPITAL. IT ALSO SHOWS HIGH AND GROWING SALES AND PROFITABILITY.

 

IT IS WORTH TO COMMENT THAT THE SUBJECT HAS A HIGH FINANCIAL STRENGTH AND SO FAR IT OPERATES NORMALLY BEING NOT LIKELY TO FACE FINANCIAL PROBLEMS.

 

REAL ESTATE:

OWNED PREMISES ARE VALUED AT R$ 727.800,00


 

DETAIL OF OWNED REAL ESTATE:

 

QUANTITY:

1

TYPE:

OTHERS

VALUE:

R$ 110.400,00

ADDRESS:

AV. ARTHUR DE QUEIROZ S/N - CASA BRANCA EM SANTO ANDRÉ/SP

 

 

QUANTITY:

1

TYPE:

BUILDING

VALUE:

R$ 736.000,00

ADDRESS:

AV. ARTHUR DE QUEIROZ, 905/915 - CASA BRANCA, EM SANTO ANDRÉ/SP

 

VEHICLES:

NOT AVAILABLE

 

MACHINES:

NOT AVAILABLE

 

 

INSURANCE

 

INSURANCE COMPANY:

MINAS-BRASIL SEGURADORA

COVERAGE:

ALL RISKS

VALUE:

R$ 18.567.680,00

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

CITY:

BANCO ITAÚ S/A

0009  /  19 3735-9709

CAMPINAS/SP

BANCO DO BRASIL S/A

2900-9  /  19 3794-9023

CAMPINAS/SP

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 


 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND TRADE OF PHARMACEUTICAL PRODUCTS.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

ITALY, GERMANY, FRANCE, CANADA, INDIA AND SWEDEN.

 

EXPORTS TO:

DOES NOT EXPORT.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

CITY:

PHONE:

DIST.DE DROGAS NORFARMA LTDA

ARAÇATUBA/SP

18 623-3645

DISTR. FARMACÊUTICA PANARELLO LTDA

GOIÂNIA/GO

62 3285-6611

DISTR. MEDICAMENTOS SANTA CRUZ LTDA

CURITIBA/PR

41 3316-2209

DISTR.DROGAS CENTRO OESTE LTDA.

CAMPO GRANDE/MS

67 382-6188

ITA REPRES. PRODS. FARMACÊUTICOS

SANTA BÁRBARA D’OESTE/SP

19 3459-4000

JAMYR VASCONCELOS S/A

RIO DE JANEIRO/RJ

21 2472-2828

PERFORMA DISTR. PRODS. FARMACÊUTICOS LTDA

RIACHO DAS PEDRAS/MG

21 3450-1416

UNIFARMA DISTRIBUISDORA FARMACEUTICA LTDA

IMPERATRIZ/MA

98 3525-3486

 

STAFF:

 

THE COMPANY HAS: 4600 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS AN OLD-ESTABLISHED COMPANY, OPERATING SINCE 1964 WITH A LEADING MARKET POSITION. IT HAS A HIGH AND GROWING SCALE OF ACTIVITIES AND AN EXCELLENT TRADE REPUTATION.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

THE LAWSUITS REPORTED ARE NOT RELATED WITH TRADE DEBTS. THEY ARE RELATED TO TAX DEBTS THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUITS DO NOT AFFECT THE COMPANY’S TRADE REPUTATION.

 

THE PROTEST IS IRRELEVANT.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

CITY:

PHONE:

ALLPLAS INDÚSTRIA.COM.PLÁSTICOS LTDA

CARAPICUIBA/SP

11  429-7443

BAFEMA S/A INDÚSTRIA E COMÉRCI0

SÃO PAULO/SP

11  246-4088

BOAINAIN DIOSTR. DE ALCOOL LTDA

OSASCO/SP

11  703-7111

CIA. UNIÃO REFINADORES AÇÚCAR E CAFÉ

SÃO PAULO/SP

11  291-6111

COLORCON DO BRASIL LTDA

COTIA/SP

11 4617-8640

ESQYEMA IND.COM.EMBALAGENS LTDA

OSASCO/SP

11  703-1577

FENIL QUÍMICA LTDA

SÃO PAULO/SP

11  548-9332

HENRIFARMA PRODS.QUI.FARM. LTDA

SÃO PAULO/SP

11  549-9933

M. CASSAB COMERCIO E INDUSTRIA LTDA

SÃO PAULO/SP

11 2162-7788

PRODUTOS ROCHE QUÍM. FARMACÊUTICA S/A

SÃO PAULO/SP

11  268-7022

VEDAT TAMPAS HERMETICAS LTDA

EMBU/SP

11 2133-1212

VITROSUL IND.COM.VIDORS LTDA

EMBÚ/SP

11  494-6877

VULCAN MARTERIAL PLÁSTICO S/A

RIO DE JANEIRO/RJ

21 3362-2037

WHEATON DO BRASIL S/A

SÃO BERNARDO CAMPO/SP

11  451-4433

 

 

PAYMENT HISTORY:

 

16 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 4.598.320,00

 

AMOUNT OF INVOICES PAID: 140

TOTAL OF PROMPT PAYMENTS: 99,8%

TOTAL OF DELAYED PAYMENTS: 0,2%

 

HIGHEST INVOICE: R$ 361.462,00

HIGHEST CREDIT: R$ 361.462,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

2

2

R$ 119.975,39,00

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS CLEAR TRADE HISTORY AND GOOD PAYMENT PERFORMANCE.

 

BASED ON THE OVERALL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S SIZE AND FINANCIAL STRENGTH.

 

AN INITIAL CREDIT LIMIT OF USD 5.000.000,00 CAN BE CONSIDERED. HIGHER AMOUNTS CAN BE GRANTED DEPENDING ON THE IMPORTANCE OF THE OPERATIONS TO BE ESTABLISHED WITH THE SUBJECT.

 

 


EMS S/A

 

 

 

 

 

 

BALANCE SHEET ANALYSIS

FIGURES ARE IN THOUSANDS OF REAIS

 

 

 

 

31-12-10

 

31-12-09

 

31-12-08

 

ASSETS

 

%

 

%

 

%

Current Assets

 $                 590,958

64.98

 $                 501,326

53.20

 $             519,368

54.59

Fixed Assets

 $                 175,045

19.25

 $                 164,314

17.44

 $             210,919

22.17

TOTAL ASSETS

 $                 909,460

100.00

 $                 942,386

100.00

 $             951,448

100.00

LIABILITIES

 

 

 

 

 

 

Current Liabilities

 $                 181,450

19.95

 $                 112,152

11.90

 $             151,071

15.88

Long-Term Liabilities

 $                 286,353

31.49

 $                 286,857

30.44

 $             237,290

24.94

TOTAL LIABILITIES

 $                 467,803

51.44

 $                 399,009

42.34

 $             388,361

40.82

Deferred Income

 $                            -  

0.00

 $                            -  

0.00

 $                        -  

0.00

Net Equity

 $                 441,657

48.56

 $                 543,377

57.66

 $             563,088

59.18

TOTAL LIABILITIES + NET EQUITY

 $                 909,460

100.00

 $                 942,386

100.00

 $             951,449

100.00

PROFIT AND LOSS ACCOUNTS

 

 

 

 

 

 

Net Sales

 $              1,213,283

100.00

 $              1,036,807

100.00

 $             829,782

100.00

Costs

 $                 444,871

36.67

 $                 440,225

42.46

 $             394,200

47.51

Gross Profit

 $                 768,412

63.33

 $                 596,582

57.54

 $             435,582

52.49

Operating expenses

 $                (433,523)

-35.73

 $                (368,082)

-35.50

 $            (241,141)

-29.06

operational Result

 $                 326,618

26.92

 $                 232,084

22.38

 $             169,266

20.40

Net Profit (loss)

 $                 234,681

19.34

 $                 165,046

15.92

 $               72,882

8.78

COMPLEMENTARY DATA

 

 

 

 

 

 

Inventory

 $                 147,183

 

 $                 139,565

 

 $             144,952

 

Accounts receivable

 $                 309,885

 

 $                 240,525

 

 $             196,032

 

Accounts Payable

 $                   64,529

 

 $                   43,540

 

 $               93,967

 

Property, plant and equipment

 $                 132,263

 

 $                 133,498

 

 $             138,261

 

Purchases

 $                 175,045

 

 $                 164,314

 

 $             210,919

 

Financial Expenses

 $                    (8,271)

 

 $                      3,584

 

 $              (25,175)

 

Foreign Currency Assets

 

 

 

 

 

 

Foreign Currency Liabilities

 

 

 

 

 

 

Working Capital

 $                 409,508

 

 $                 389,174

 

 $             368,297

 

RATIOS:

 

 

 

 

 

 

QUICK RATIO

                           2.45

 

                           3.23

 

                       2.48

 

CURRENT RATIO

                           3.26

 

                           4.47

 

                       3.44

 

ACCOUNTS RECEIVABLE TURNOVER

                           3.92

times

                           4.31

times

                       4.23

times

DAYS' SALES IN RECEIVABLES

                         91.95

days

                         83.52

days

                     85.05

days

INVENTORY TURNOVER

                           3.02

times

                           3.15

times

                       2.72

times

ACCOUNTS PAYABLE PERIOD

                         52.22

days

                         35.61

days

                     85.81

days

RETURN ON ASSETS

                           1.33

times

                           1.10

times

                       0.87

times

SALES TURNOVER ON NET EQUIY

                           2.75

times

                           1.91

times

                       1.47

times

NET WORTH TIE-UP

                           0.30

 

                           0.25

 

                       0.25

 

ENDEBTEDNESS

                           1.06

 

                           0.73

 

                       0.69

 

EQUITY RATIO

                         48.56

%

                         57.66

%

                     59.18

%

WORKING CAPITAL RATIO

                       225.69

%

                       347.01

%

                   243.79

%

GENERAL SOLVENCY

                           1.94

 

                           2.36

 

                       2.45

 

RETURN ON NET EQUITY

                         53.14

%

                         30.37

%

                     12.94

%

RETURN ON SALES (PROFIT MARGIN)

                         19.34

%

                         15.92

%

                       8.78

%

GROSS PROFIT MARGIN

                         63.33

%

                         57.54

%

                     52.49

%

OPERATIONAL RESULT

                         26.92

%

                         22.38

%

                     20.40

%

SALES TURNOVER ON LIABILITIES

                           6.69

times

                           9.24

times

                       5.49

times

FOREIGN CURRENCY ON ASSETS

                               -  

%

                               -  

%

                           -  

%

FOREIGN CURRENCY ON LIABILITIES

                               -  

%

                               -  

%

                           -  

%

 

 


 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.28

UK Pound

1

Rs.81.38

Euro

1

Rs.67.01

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.